VP and CFO of Neurocrine Biosciences Inc. (NBIX, Financial) Timothy P Coughlin sells 12,650 shares of NBIX on 03/01/2010 at an average price of $2.53 a share.
Neurocrine Biosciences Inc. has a market cap of $103.1 million; its shares were traded at around $2.63 with and P/S ratio of 34.9. Neurocrine Biosciences Inc. had an annual average earning growth of 21.7% over the past 5 years.
NBIX is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Jim Simons of Renaissance Technologies LLC.
Neurocrine Biosciences Inc. has a market cap of $103.1 million; its shares were traded at around $2.63 with and P/S ratio of 34.9. Neurocrine Biosciences Inc. had an annual average earning growth of 21.7% over the past 5 years.
NBIX is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell:: President and CEO Kevin Charles Gorman sold 9,445 shares of NBIX stock on 01/12/2010 at the average price of 2.52, the price of the stock has increased by 4.37% since.
CFO Recent Trades:
- Sell:: VP and CFO Timothy P Coughlin sold 8,697 shares of NBIX stock on 01/12/2010 at the average price of 2.52, the price of the stock has increased by 4.37% since.
Directors and Officers Recent Trades:
- Buy:: Director W Thomas Mitchell bought 900 shares of NBIX stock on 11/05/2009 at the average price of 2.17, the price of the stock has increased by 21.2% since.
- Sell:: EVP and General Counsel Jensen Margaret E Valeur sold 8,697 shares of NBIX stock on 01/12/2010 at the average price of 2.52, the price of the stock has increased by 4.37% since.
- Sell:: Sr. VP & Chief Medical Officer Christopher Flint Obrien sold 1,503 shares of NBIX stock on 01/04/2010 at the average price of 2.65, the price of the stock has decreased by 0.75% since.
- Sell:: Sr Vice President, Development Haig P. Bozigian sold 751 shares of NBIX stock on 01/04/2010 at the average price of 2.64, the price of the stock has decreased by 0.38% since.
- Sell:: Vice President, Research Dimitri E. Grigoriadis sold 1,503 shares of NBIX stock on 01/04/2010 at the average price of 2.67, the price of the stock has decreased by 1.5% since.
